Retatrutide is the latest generation in multi-agonist peptide research, targeting three receptors simultaneously: GIP, GLP-1, and Glucagon. This triple-receptor mechanism represents the current frontier in metabolic peptide science.
We examine the rationale for adding glucagon receptor activation to the GIP/GLP-1 dual mechanism, how this is thought to influence energy expenditure and lipid metabolism, and what the current research literature suggests about its effects in controlled studies.
Triple-receptor highlights:
- Simultaneous activation of GIP, GLP-1, and Glucagon pathways
- Research into effects on metabolic rate and thermogenesis
- Comparative studies vs dual and single agonists
For research purposes only. Not for human consumption.